We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$125B
AUM Growth
+$2.58B
Cap. Flow
-$3.77B
Cap. Flow %
-3.02%
Top 10 Hldgs %
25.94%
Holding
7,845
New
463
Increased
3,647
Reduced
2,883
Closed
246

Sector Composition

Rank Sector Weight
1 Financials 4.66%
2 Technology 4.22%
3 Healthcare 2.96%
4 Consumer Discretionary 2.91%
5 Industrials 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIND
7001
Vyome Holdings
HIND
$14M
0
SIVR icon
7002
CALL
abrdn Physical Silver Shares ETF
SIVR
$3.97B
$8K ﹤0.01%
500
-6,800
-93% -$111K
SPRO icon
7003
Spero Therapeutics
SPRO
$69.5M
$8K ﹤0.01%
+681
New +$8.36K
TCI icon
7004
Transcontinental Realty Investors
TCI
$368M
$8K ﹤0.01%
261
+232
+800% +$6.95K
TPST icon
7005
Tempest Therapeutics
TPST
$13.9M
$8K ﹤0.01%
2
VANI icon
7006
Vivani Medical
VANI
$113M
$8K ﹤0.01%
166
-20
-11% -$664
VNDA icon
7007
PUT
Vanda Pharmaceuticals
VNDA
$310M
$8K ﹤0.01%
500
XBIT icon
7008
XBiotech
XBIT
$69.2M
$8K ﹤0.01%
1,991
+650
+48% +$2.74K
LGF.A
7009
PUT
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$8K ﹤0.01%
250
HYB
7010
DELISTED
New America High Income Fund, Inc.
HYB
$8K ﹤0.01%
800
-8,567
-91% -$83.3K
AKTS
7011
DELISTED
Akoustis Technologies Inc
AKTS
$8K ﹤0.01%
1,222
+1,187
+3,391% +$7.47K
ARAV
7012
DELISTED
Aravive, Inc. Common Stock
ARAV
$8K ﹤0.01%
588
-3,784
-87% -$48.7K
IBDO
7013
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$8K ﹤0.01%
300
PRTK
7014
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$8K ﹤0.01%
452
-1,407
-76% -$29.4K
VIVE
7015
DELISTED
VIVEVE MED INC
VIVE
$8K ﹤0.01%
+2
New +$10.4K
FGP
7016
CALL
DELISTED
Ferrellgas Partners, L.P.
FGP
$8K ﹤0.01%
1,900
+1,600
+533% +$7.38K
SDT
7017
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
$8K ﹤0.01%
10,000
TI.A
7018
DELISTED
Telecom Italia 10 Svg
TI.A
$8K ﹤0.01%
1,034
+665
+180% +$4.74K
KONA
7019
DELISTED
Kona Grill, Inc.
KONA
$8K ﹤0.01%
+4,664
New +$12.4K
CXRX
7020
DELISTED
Concordia International Corp. Common Stock
CXRX
$8K ﹤0.01%
12,667
CXRX
7021
PUT
DELISTED
Concordia International Corp. Common Stock
CXRX
$8K ﹤0.01%
11,700
NFO
7022
DELISTED
Invesco Insider Sentiment ETF
NFO
$8K ﹤0.01%
128
-2
-2% -$123
WLB
7023
DELISTED
Westmoreland Coal Company
WLB
$8K ﹤0.01%
6,867
-7,369
-52% -$12.7K
AST
7024
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$8K ﹤0.01%
3,578
+2,907
+433% +$7.36K
PKO
7025
DELISTED
Pimco Income Opportunity Fund
PKO
$8K ﹤0.01%
325
-628
-66% -$16.4K

Similar funds

Citigroup's Q4 2017 Portfolio in Review

As of Q4 2017, Citigroup held 7,845 positions worth $125B, up 2.1% from $122B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Citigroup withdrew a net $3.77B in Q4 2017, closing 246 positions and reducing 2,883 holdings. Its most notable exit was CR Bard Inc., an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.7% of assets, up from 4.4% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Citigroup opened a new position in Global X US Preferred ETF worth $19.9M.

  • Citigroup's largest Q4 2017 buy was Global X US Preferred ETF: 800,000 shares worth $19.9M.
  • Citigroup added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2017, an estimated $341M increase.
  • Citigroup's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.83B.
  • Citigroup fully exited CR Bard Inc. in Q4 2017, selling an estimated $210M.
  • Citigroup's ten largest holdings make up 26% of its $125B portfolio in Q4 2017.
  • Citigroup opened 463 new positions and closed 246 in Q4 2017.
  • Citigroup's portfolio value rose 2.1% quarter-over-quarter to $125B.

Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.